MetLife Investment Management’s Southern Company SO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $24.7M | Buy |
257,921
+625
| +0.2% | +$58.8K | 0.11% | 135 |
|
|
2026
Q1 | $24.8M | Sell |
257,296
-6,677
| -3% | -$618K | 0.13% | 126 |
|
|
2025
Q4 | $23M | Sell |
263,973
-8,998
| -3% | -$821K | 0.11% | 137 |
|
|
2025
Q3 | $25.9M | Sell |
272,971
-7,119
| -3% | -$665K | 0.12% | 116 |
|
|
2025
Q2 | $25.7M | Sell |
280,090
-4,486
| -2% | -$403K | 0.15% | 101 |
|
|
2025
Q1 | $26.2M | Sell |
284,576
-5,423
| -2% | -$469K | 0.14% | 106 |
|
|
2024
Q4 | $23.9M | Buy |
289,999
+5,648
| +2% | +$496K | 0.13% | 115 |
|
|
2024
Q3 | $25.6M | Sell |
284,351
-7,331
| -3% | -$626K | 0.15% | 109 |
|
|
2024
Q2 | $22.6M | Buy |
291,682
+36,332
| +14% | +$2.75M | 0.13% | 119 |
|
|
2024
Q1 | $18.3M | Sell |
255,350
-9,392
| -4% | -$648K | 0.12% | 126 |
|
|
2023
Q4 | $18.6M | Sell |
264,742
-4,987
| -2% | -$342K | 0.13% | 120 |
|
|
2023
Q3 | $17.5M | Sell |
269,729
-7,024
| -3% | -$487K | 0.14% | 123 |
|
|
2023
Q2 | $19.4M | Sell |
276,753
-4,184
| -1% | -$300K | 0.14% | 117 |
|
|
2023
Q1 | $19.5M | Sell |
280,937
-3,367
| -1% | -$227K | 0.14% | 111 |
|
|
2022
Q4 | $20.3M | Buy |
284,304
+2,171
| +0.8% | +$145K | 0.15% | 111 |
|
|
2022
Q3 | $19.2M | Sell |
282,133
-4,088
| -1% | -$310K | 0.16% | 108 |
|
|
2022
Q2 | $20.4M | Sell |
286,221
-2,111
| -0.7% | -$155K | 0.16% | 105 |
|
|
2022
Q1 | $20.9M | Buy |
288,332
+54,178
| +23% | +$3.67M | 0.14% | 115 |
|
|
2021
Q4 | $16.1M | Sell |
234,154
-4,992
| -2% | -$318K | 0.13% | 124 |
|
|
2021
Q3 | $14.8M | Sell |
239,146
-6,292
| -3% | -$405K | 0.13% | 127 |
|
|
2021
Q2 | $14.9M | Sell |
245,438
-6,351
| -3% | -$406K | 0.13% | 130 |
|
|
2021
Q1 | $15.7M | Sell |
251,789
-4,724
| -2% | -$283K | 0.14% | 125 |
|
|
2020
Q4 | $15.8M | Sell |
256,513
-11,262
| -4% | -$677K | 0.15% | 119 |
|
|
2020
Q3 | $14.5M | Sell |
267,775
-8,396
| -3% | -$449K | 0.16% | 114 |
|
|
2020
Q2 | $14.3M | Buy |
276,171
+5,847
| +2% | +$325K | 0.16% | 118 |
|
|
2020
Q1 | $14.6M | Sell |
270,324
-8,271
| -3% | -$524K | 0.2% | 101 |
|
|
2019
Q4 | $17.7M | Sell |
278,595
-5,850
| -2% | -$363K | 0.18% | 103 |
|
|
2019
Q3 | $17.6M | Sell |
284,445
-2,449
| -0.9% | -$142K | 0.19% | 97 |
|
|
2019
Q2 | $15.9M | Sell |
286,894
-595,346
| -67% | -$31.9M | 0.17% | 108 |
|
|
2019
Q1 | $45.6M | Buy |
882,240
+587,996
| +200% | +$28.8M | 0.14% | 112 |
|
|
2018
Q4 | $12.9M | Sell |
294,244
-771
| -0.3% | -$35K | 0.16% | 117 |
|
|
2018
Q3 | $12.9M | Sell |
295,015
-2,784
| -0.9% | -$128K | 0.13% | 143 |
|
|
2018
Q2 | $13.8M | Sell |
297,799
-5,595
| -2% | -$250K | 0.16% | 112 |
|
|
2018
Q1 | $13.6M | Sell |
303,394
-7,136
| -2% | -$317K | 0.16% | 120 |
|
|
2017
Q4 | $14.9M | Buy |
+310,530
| New | +$15.8M | 0.17% | 118 |
|
Other funds holding SO
MetLife Investment Management's SO Position: Q2 2026 in Review
MetLife Investment Management increased its Southern Company (SO) stake by 0.24% in Q2 2026, buying an estimated $58.8K and bringing the position to 257,921 shares worth $24.7M. The position accounts for 0.11% of the portfolio, ranked #135.
MetLife Investment Management first reported a position in SO in Q4 2017 and has held it in 35 quarters since. The position peaked at $45.6M in Q1 2019. 2,352 funds tracked by Wall St. Rank hold SO as of Q2 2026.
- MetLife Investment Management held 257,921 shares of Southern Company worth $24.7M as of Q2 2026.
- MetLife Investment Management bought 625 Southern Company shares in Q2 2026, an estimated $58.8K.
- Southern Company made up 0.11% of MetLife Investment Management's portfolio in Q2 2026, its #135 holding.
- MetLife Investment Management first reported a position in Southern Company in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Southern Company position peaked at $45.6M in Q1 2019.
- 2,352 funds tracked by Wall St. Rank held Southern Company as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.